Literature DB >> 18585368

Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein.

Giannantonio Panza1, Jan Stöhr, Christian Dumpitak, Dimitrios Papathanassiou, Jürgen Weiss, Detlev Riesner, Dieter Willbold, Eva Birkmann.   

Abstract

The conversion of the cellular isoform of the prion protein into the pathogenic isoform PrP(Sc) is the key event in prion diseases. The disease can occur spontaneously genetically or by infection. In earlier studies we presented an in vitro conversion system which simulates the structural transition in recPrP by varying low concentrations of SDS at constant NaCl. In the present study we adopted the conversion system from experimental Scrapie in hamster to bovine recPrP and generated amyloid fibrils. The intermediate state which is optimal for fibril formation is a soluble, beta-rich state. The system was extended using BSE-prions as seeds and led to an acceleration of fibril formation by orders of magnitude. This seeded amyloid formation assay avoids any PK-treatment, is therefore able to detect even PK-sensitive PrP(Sc) and does not require cellular components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585368     DOI: 10.1016/j.bbrc.2008.06.059

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Prion infection: seeded fibrillization or more?

Authors:  Eva Birkmann; Detlev Riesner
Journal:  Prion       Date:  2008-04-23       Impact factor: 3.931

2.  Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein.

Authors:  Christina D Orrú; Jason M Wilham; Andrew G Hughson; Lynne D Raymond; Kristin L McNally; Alex Bossers; Ciriaco Ligios; Byron Caughey
Journal:  Protein Eng Des Sel       Date:  2009-07-01       Impact factor: 1.650

3.  Effect of mid-infrared free-electron laser irradiation on refolding of amyloid-like fibrils of lysozyme into native form.

Authors:  Takayasu Kawasaki; Jun Fujioka; Takayuki Imai; Koichi Tsukiyama
Journal:  Protein J       Date:  2012-12       Impact factor: 2.371

4.  Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.

Authors:  Giannantonio Panza; Lars Luers; Jan Stöhr; Luitgard Nagel-Steger; Jürgen Weiss; Detlev Riesner; Dieter Willbold; Eva Birkmann
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

5.  Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Authors:  Christina D Orrú; Jason M Wilham; Lynne D Raymond; Franziska Kuhn; Björn Schroeder; Alex J Raeber; Byron Caughey
Journal:  MBio       Date:  2011-05-10       Impact factor: 7.867

6.  Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases.

Authors:  Fangzhong Yuan; Lifeng Yang; Zhuming Zhang; Wenyu Wu; Xiangmei Zhou; Xiaomin Yin; Deming Zhao
Journal:  J Mol Neurosci       Date:  2013-05-30       Impact factor: 3.444

7.  Progress towards structural understanding of infectious sheep PrP-amyloid.

Authors:  Henrik Müller; Oleksandr Brener; Olivier Andreoletti; Timo Piechatzek; Dieter Willbold; Giuseppe Legname; Henrike Heise
Journal:  Prion       Date:  2014       Impact factor: 3.931

8.  Seeded fibrillation as molecular basis of the species barrier in human prion diseases.

Authors:  Lars Luers; Oliver Bannach; Jan Stöhr; Michael Marius Wördehoff; Martin Wolff; Luitgard Nagel-Steger; Detlev Riesner; Dieter Willbold; Eva Birkmann
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.